# Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer

> **NCT06398639** · NA · RECRUITING · sponsor: **Adam S. Kibel, MD** · enrollment: 1500 (estimated)

## Conditions studied

- Prostate Cancer
- Polygenic Risk Score

## Interventions

- **OTHER:** Polygenic Risk Score (PRS)

## Key facts

- **NCT ID:** NCT06398639
- **Lead sponsor:** Adam S. Kibel, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-07
- **Primary completion:** 2028-04-30
- **Final completion:** 2030-04-30
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06398639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06398639, "Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT06398639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*